FDA-Compliant SBOM for Cardiovascular Devices
FDA-aligned SBOMs for pacemakers, ICDs, monitors, and remote-follow cloud - implant firmware, programmer software, and 10+ year postmarket SBOM monitoring.
Last reviewed March 2026 · Reviewed against the FDA Feb 3, 2026 final premarket cybersecurity guidance.
Cardiovascular SBOM work is uniquely a postmarket problem. The implant ships, lives in a patient for 10+ years, and the SBOM you submitted on day one is the SBOM you have to maintain and monitor for the device's lifetime under FDA's postmarket cybersecurity guidance and Section 524B. Our SBOM service for this segment is built around that reality: a complete day-one SBOM across implant, programmer, home monitor, and cloud - plus a postmarket SBOM monitoring program that produces VEX-quality determinations as new CVEs land.
For the implant we extract third-party libraries from the firmware build (often a custom RTOS or proprietary scheduler) and document cryptographic libraries, communication stacks, and any open-source components - most implants have more OSS than their teams initially believe. The clinician programmer, typically Windows-based, gets a full OS + application SBOM. The home monitor gets an embedded-Linux-style SBOM. The remote-follow cloud (the highest churn surface) gets pipeline-integrated SBOM generation per build. We then operate ongoing monitoring against NVD/OSV/GHSA with auto-generated VEX drafts that your team triages - because for a 10-year deployed fleet, 'we'll review it next quarter' is not a postmarket cybersecurity strategy. Reports are formatted to slot directly into PMA Annual Reports and 524B postmarket plans.
Layers we exercise in this engagement
The cardiovascular system, from the outermost cloud and clinician surfaces down to the device itself. Highlighted layers are exercised by this fda-compliant sbom services.
- 01Cloud backend libs Tested
- 02Mobile companion deps Tested
- 03Home-monitor firmware Tested
- 04Programmer software Tested
- 05Implant firmware components Tested
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
FDA-Compliant SBOM Services engagement, end to end
Four phases, fixed fee, scoped to cardiovascular architecture from kickoff onward.
-
01
Build-pipeline integration
CycloneDX 1.5 / SPDX 2.3 SBOMs generated from your actual build, not from runtime introspection alone.
-
02
Enrichment + triage
Components enriched from NVD, OSV, and GHSA; every CVE above your threshold triaged for exploitability.
-
03
VEX authoring
Per-CVE VEX statements (not_affected, affected, fixed, under_investigation) with reviewer-grade justifications.
-
04
Postmarket handoff
SBOM + VEX delivery hooked into your QMS so postmarket monitoring continues after submission.
What we see in Cardiovascular fda-compliant sbom services
The patterns we hit in this segment, this service, again and again.
-
Implant cryptographic library pulled in transitively
RNG / AES library inherited from a vendor SDK, never inventoried. Found via firmware-image SBOM extraction, not source-tree analysis.
-
Programmer Windows base components missing from SBOM
Application-only SBOM hides the OS attack surface. Programmer-side CVEs landed without product-team awareness for two cycles.
-
Cloud follow-up service SBOM not regenerated per build
Annual SBOM snapshot bears no resemblance to what's currently in production. Deployed components diverge silently from the regulatory record.
-
No postmarket VEX cadence
SBOM submitted and forgotten. New CVEs in OpenSSL / Linux kernel land with no exploitability determination on file when reviewers ask.
"Blue Goat Cyber helped us navigate our first end-to-end cybersecurity testing for our wearable medical device. Their communication was excellent, their timeline exceeded expectations, and their report helped us achieve FDA clearance without any additional questions. It was a truly seamless experience."
Standard FDA-Compliant SBOM Services deliverables
The same deliverables the parent FDA-Compliant SBOM Services service ships with - tuned to your cardiovascular architecture.
- SPDX and CycloneDX generation
- Component vulnerability mapping (CVE / KEV)
- End-of-life and replacement planning
- Build-system and binary SCA validation
What lands in your eSTAR submission
Reviewer-format documents ready to drop straight into the cybersecurity attachments of your submission - no reformatting on your side.
- SPDX and CycloneDX generation
- Component vulnerability mapping (CVE / KEV)
- End-of-life and replacement planning
- Build-system and binary SCA validation
Standards that apply
The Cardiovascular baseline, plus the call-outs that matter for fda-compliant sbom services in this segment.
Segment-specific call-outs
FDA postmarket cybersecurity guidance + 524B postmarket clauses
Cardiac fleets are the canonical use case - SBOM monitoring is not optional for this segment.
AAMI TIR97
Postmarket cyber surveillance framework FDA reviewers explicitly reference for implant fleets.
What's not in scope
We scope tightly on purpose. These items are either out-of-scope by design or belong in a separate engagement - we'll tell you up front, not after kickoff.
- Penetration testing of components in the SBOM
- Code refactoring to remove vulnerable dependencies
- License-compliance legal review (we surface, your counsel rules)
FDA-Compliant SBOM Services for Cardiovascular - FAQs
The questions buyers in this segment actually ask before scoping a fda-compliant sbom services engagement.
Go deeper on Cardiovascular and premarket
A practical, ungated buyer's guide for medical device manufacturers evaluating cybersecurity partners, what goes wrong, why it costs you, and what to demand from your next engagement. Aligned to the FDA February 2026 premarket guidance.
What CR34971 adds on top of ISO 14971, the AI-specific risk categories it covers, and how to integrate it with your existing risk file.
250+ 0 6–10 wk FDA submissions supported Cybersecurity rejections Class II eSTAR cyber pack SINCE 2014 TRACK RECORD TYPICAL TIMELINE
What happens if you fail an FDA cybersecurity inspection: the 483-to-consent-decree enforcement ladder and the commercial fallout for device makers.
FDA Section 524B applies to any new premarket submission for a cyber device, including legacy platforms. What attaches, what postmarket rules cover the rest.
SPDF vs SSDLC for medical devices. Why the FDA's Secure Product Development Framework demands more than a standard Secure SDLC, and what to add.
Other engagements for Cardiovascular
Teams in this segment commonly bundle these alongside fda-compliant sbom services.
Keep going
Scope a FDA-Compliant SBOM Services engagement for your cardiovascular program.
A 30-minute call with a senior engineer who has done this in cardiovascular before - not a sales rep.